LivaNova PLC (LIVN)
LivaNova PLC is a healthcare equipment company listed on NASDAQ under the ticker LIVN. The company develops, manufactures, markets, and sells medical technology products, therapies, and related services in the United States, Europe, and other international markets. Its operations are organized into two reportable segments: Cardiopulmonary and Neuromodulation.
The Cardiopulmonary segment includes products such as heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and related accessories, along with associated services. The Neuromodulation segment offers the VNS Therapy System, which is used in therapy delivery through an implantable pulse generator and lead system, as well as surgical equipment and supporting materials for implantation procedures. This segment also includes devices used in neuromodulation therapy for drug-resistant epilepsy and difficult-to-treat depression, and development work on the aura6000 system for obstructive sleep apnea.
LivaNova serves perfusionists, neurologists, neurosurgeons, hospitals, and other healthcare providers. The company was incorporated in 2015 and is headquartered in London, United Kingdom.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-LIVN
|
$77
|
-1.8% Downside
|
Fair
|
$89.10
|
13.6% Upside
|
Fair
|
Great
|
0.0%
|
November 4, 2026
|
22.8x
|
3.2x
|
2.9x
|
4.324 B
|
4.139 B
|
7.6%
|
99.5%
|
4.4
|
78.7%
|
